November 5, 2013
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | GlycoMimetics, Inc. (the Company) Request for Acceleration |
Registration Statement on Form S-1 (File No. 333-191567)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the Act), and as Representatives of the several underwriters of the Companys proposed public offering of common shares, we hereby join the Companys request for acceleration of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:00 p.m. Eastern Time on November 7, 2013, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the Act, we wish to advise you that we have distributed approximately 3,105 copies of the Companys Preliminary Prospectus dated October 28, 2013 through the date hereof to underwriters, dealers, institutions and others.
We, the undersigned, as Representatives of the several underwriters, have and will, and we have been informed by the participating underwriters that they have complied and will continue to comply, with the provisions of Rule 15c2-8 of the Securities Exchange Act of 1934, as amended.
[Signature Page Follows]
Very truly yours, | ||||
Jefferies LLC Barclays Capital Inc. | ||||
As Representatives of the several Underwriters | ||||
By: | Jefferies LLC | |||
By: | /s/ Ashley Delp | |||
Name: | Ashley Delp | |||
Title: | Managing Director | |||
By: | Barclays Capital Inc. | |||
By: | /s/ Victoria Hale | |||
Name: | Victoria Hale | |||
Title: | Vice President |